SAGE: Sage Therapeutics Inc Narxning sof foyda o‘sishiga nisbati

Sage Therapeutics Inc (SAGE) tovar belgisi

Sage Therapeutics, Inc. (SAGE) kompaniyasida tadqiqot va ishlanmalar (R&D) bo'yicha maqsadlarga erishilmaganligi sababli operatsion dinamikaning zaifligi pul oqimlariga salbiy ta'sir ko'rsatmoqda. Biroq, sog'liqni saqlash gigantlari bilan hamkorlikdagi aktivlarsiz strategiya kompaniyaga zavod xarajatlarisiz yuqori marjali sotuvlarni kengaytirish imkonini beradi. PEG momentum ko'rsatkichi baholash dinamikasini aks ettiradi, bunda parametr qiymati 0.00 ga tengdir. Daromadlar sug'urta tizimlari va dorixonalari orqali depressiyadan aziyat chekuvchi bemorlar uchun terapiyalarning tijoratlashtirilishiga asoslangan.

SAGE Sage Therapeutics Inc. Narx-foyda va o‘sish multiplikatori (04.07.2022 - 16.08.2025)

Sage Therapeutics (SAGE) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:SAGE - Sage Therapeutics Inc
sagerx.com brendining mahsuloti

Yuqori sifatli portfelni shakllantirish uchun men biznesning bozor qiymatini uning foyda o'sishi bilan bog'laydigan PEG koeffitsiyentidan foydalanaman, bu ko'rsatkich birdan past bo'lganda qadrsiz aktivlarni aniqlash imkonini beradi. peg_co koeffitsiyentini tahlil qilish bozorning Sage Therapeutics, Inc. (SAGE) innovatsion depressiya terapiyalarining sotuv salohiyatini joriy aksiya narxiga qanchalik samarali kiritayotganini baholash imkonini beradi.

Sage Therapeutics, Inc. raqobatchilari

O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX (Scilex Holding Company) - Narx-foyda va o‘sish multiplikatori|TVGN (Tevogen Bio Holdings) - Narxning foydaga va o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Corp) - PEG multiplikatori|Cognition Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori IKT|SAVA (Cassava) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Assertio Holdings, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti COYA|VistaGen Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics OVID|ABOS: PEG multiplikatori|CervoMed Corporation (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Limited|Narxning foydaga va o‘sish sur’atiga nisbati CLNN|PEG multiplikatori PEPG|JUNS (Jupiter Neurosciences) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Corp RLMD|PEG multiplikatori Annovis Bio Corporation ANVS|gracetx.com - PEG multiplikatori|Firefly Neuroscience, Inc (AIFF) - Narx-foyda va o‘sish multiplikatori|Klotho Neurosciences (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics, Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|RVPH (Reviva Pharmaceuticals Holdings) - PEG multiplikatori|MetaVia Inc (MTVA) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori NRXS|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Helius Medical Technologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati passagebio.com PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|Athira - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ADXN: PEG multiplikatori|ALZN (Alzamend Neuro, Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|PTIX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori KTTA|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CRGT|Avenue Therapeutics Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BCLI|CARA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CHRO (Chromocell Therapeutics Corp)|ELYM: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ITCI|Narxning foydaga va o‘sish sur’atiga nisbati Longboard Pharmaceuticals Inc|marinuspharma.com (MRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NKGN (NKGen Biotech, Inc.)|NRBO - O‘sish sur’atiga tuzatilgan narx-foyda|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori